Apraglutide
Modify Date: 2025-08-25 13:06:36
Apraglutide structure
|
Common Name | Apraglutide | ||
|---|---|---|---|---|
| CAS Number | 1295353-98-8 | Molecular Weight | 3765.25 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C172H263N43O52 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ApraglutideApraglutide (FE 203799), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum[1]. |
| Name | Apraglutide |
|---|
| Description | Apraglutide (FE 203799), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Apraglutide (FE 203799; 5 mg/kg/dose, subcutaneously, twice on days 0 and 4 postsurgery) treated piglets are healthy, have significant lower fecal fat and energy losses and exhibite intestinal lengthening, greater small-intestinal weight, longer villus height, and greater crypt depth on day 7[1]. Animal Model: NewbornDuroc piglets, 2–5 days old and weighing between 2-2.6 kg[1]. Dosage: 5 mg/kg/dose. Administration: Subcutaneously, twice on days 0 and 4 postsurgery. Result: On day 7, treated piglets were healthy, had significant lower fecal fat and energy losses and exhibited intestinal lengthening, greater small-intestinal weight, longer villus height, and greater crypt depth. |
| References |
| Molecular Formula | C172H263N43O52 |
|---|---|
| Molecular Weight | 3765.25 |
| Storage condition | -20°C |
| Hazard Codes | Xn |
|---|